Davita Inc (DVA) Shares Bought by ING Groep NV

ING Groep NV grew its position in shares of Davita Inc (NYSE:DVA) by 80.1% in the 4th quarter, Holdings Channel reports. The fund owned 6,494 shares of the company’s stock after acquiring an additional 2,888 shares during the period. ING Groep NV’s holdings in Davita were worth $469,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. Coastline Trust Co increased its stake in Davita by 6.3% during the fourth quarter. Coastline Trust Co now owns 16,120 shares of the company’s stock worth $1,165,000 after acquiring an additional 950 shares during the last quarter. Public Employees Retirement Association of Colorado increased its stake in Davita by 3.5% during the fourth quarter. Public Employees Retirement Association of Colorado now owns 29,076 shares of the company’s stock worth $2,101,000 after acquiring an additional 974 shares during the last quarter. Creative Planning increased its stake in Davita by 8.6% during the fourth quarter. Creative Planning now owns 13,137 shares of the company’s stock worth $949,000 after acquiring an additional 1,044 shares during the last quarter. Crossmark Global Holdings Inc. increased its stake in Davita by 7.0% during the fourth quarter. Crossmark Global Holdings Inc. now owns 25,163 shares of the company’s stock worth $1,818,000 after acquiring an additional 1,650 shares during the last quarter. Finally, Founders Capital Management LLC increased its stake in Davita by 2.3% during the third quarter. Founders Capital Management LLC now owns 95,939 shares of the company’s stock worth $5,698,000 after acquiring an additional 2,115 shares during the last quarter. Institutional investors own 84.45% of the company’s stock.

In other news, insider James K. Hilger sold 5,608 shares of the company’s stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $69.46, for a total value of $389,531.68. Following the completion of the sale, the insider now owns 47,649 shares of the company’s stock, valued at $3,309,699.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, VP Leanne M. Zumwalt sold 949 shares of the company’s stock in a transaction dated Friday, December 8th. The stock was sold at an average price of $68.19, for a total value of $64,712.31. Following the completion of the sale, the vice president now directly owns 12,423 shares of the company’s stock, valued at approximately $847,124.37. The disclosure for this sale can be found here. Insiders sold 121,509 shares of company stock valued at $8,310,388 in the last ninety days. Company insiders own 2.10% of the company’s stock.

Shares of Davita Inc (DVA) opened at $73.65 on Friday. Davita Inc has a 1 year low of $52.51 and a 1 year high of $80.71. The company has a quick ratio of 1.35, a current ratio of 2.88 and a debt-to-equity ratio of 1.87. The firm has a market capitalization of $13,438.33, a PE ratio of 21.41, a PEG ratio of 1.65 and a beta of 0.99.

Davita (NYSE:DVA) last issued its earnings results on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.94 by ($0.02). Davita had a return on equity of 12.86% and a net margin of 4.65%. The company had revenue of $2.78 billion during the quarter, compared to analysts’ expectations of $3.90 billion. During the same period in the previous year, the company earned $0.98 EPS. research analysts expect that Davita Inc will post 4.18 EPS for the current fiscal year.

DVA has been the subject of several research analyst reports. Wolfe Research upgraded Davita from a “market perform” rating to an “outperform” rating in a research note on Monday, October 23rd. Bank of America dropped their price target on Davita from $75.00 to $66.00 and set a “neutral” rating for the company in a research note on Wednesday, November 8th. Raymond James Financial upgraded Davita from an “outperform” rating to a “strong-buy” rating and upped their price target for the stock from $65.00 to $84.00 in a research note on Thursday, December 7th. Royal Bank of Canada dropped their price target on Davita from $64.00 to $60.00 and set a “sector perform” rating for the company in a research note on Wednesday, November 8th. Finally, JPMorgan Chase & Co. upped their price target on Davita from $4.90 to $84.00 and gave the stock a “strong-buy” rating in a research note on Thursday, December 7th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the company. Davita presently has an average rating of “Hold” and a consensus target price of $79.30.

ILLEGAL ACTIVITY NOTICE: “Davita Inc (DVA) Shares Bought by ING Groep NV” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/18/davita-inc-dva-shares-bought-by-ing-groep-nv.html.

Davita Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply